Rhumbline Advisers Has $42.03 Million Holdings in The Clorox Company (NYSE:CLX)

Rhumbline Advisers trimmed its stake in The Clorox Company (NYSE:CLX) by 4.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 258,815 shares of the company’s stock after selling 11,272 shares during the period. Rhumbline Advisers owned about 0.21% of Clorox worth $42,034,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its position in shares of Clorox by 36.8% during the 4th quarter. Blue Trust Inc. now owns 1,249 shares of the company’s stock valued at $203,000 after acquiring an additional 336 shares in the last quarter. Asset Planning Inc acquired a new stake in Clorox during the fourth quarter valued at approximately $32,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Clorox in the 4th quarter valued at approximately $374,000. Retirement Guys Formula LLC raised its holdings in shares of Clorox by 7.7% in the 4th quarter. Retirement Guys Formula LLC now owns 5,450 shares of the company’s stock worth $885,000 after buying an additional 389 shares in the last quarter. Finally, Kentucky Trust Co bought a new position in shares of Clorox during the 4th quarter worth approximately $428,000. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Stock Down 1.9 %

Shares of NYSE:CLX opened at $147.91 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The stock has a market cap of $18.31 billion, a price-to-earnings ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a 50 day moving average of $159.17 and a 200-day moving average of $159.61. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm posted $2.16 earnings per share. On average, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.